Status:
NOT_YET_RECRUITING
Evaluation and Refinement of KF-STRIDE Into the Interview!
Lead Sponsor:
Kessler Foundation
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Examine the acceptability, usability, feasibility, and initial efficacy of KF-STRIDE 3.0, the data from which will serve as a basis for a future fully powered RCT
Detailed Description
Although KF-STRIDE 2.0 was designed to support youth on the spectrum, its current design may not be appropriate for adults. Thus, the current proposal will support development activities to significan...
Eligibility Criteria
Inclusion
- You live in the United States of America
- You speak English Fluently and at a 4th grade reading level
Exclusion
- You have a history of significant psychiatric illness (like bipolar disorder, schizophrenia, or psychosis)
- You have a history of substance abuse
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07168941
Start Date
October 1 2025
End Date
October 1 2026
Last Update
September 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kessler Foundation
East Hanover, New Jersey, United States, 07420